h1n1

NanoViricides’ drug FluCide found safe in small animal studies

October 24, 2013 bjohnson56 0

Early results for the new flu drug FluCide® found to be safe in a non-GLP small animal safety/ toxicology study. These preliminary results support the company’s earlier reports of the FluCide® drug being effective in animal models of different influenza A virus strains. NanoViricides is also developing drugs against HIV/AIDS (HivCide™-I), Dengue (DengueCide™-I), and External Eye Viral disease (EKC-Cide™-I), amongst other viral diseases.

TapImmune Taps Into Cancer Defense

February 9, 2010 vanderson 0

How do cancer cells evade the immune system, growing undetected until they’re discovered as a tumor?

Bioguard Wound Dressings Beat Swine Flu In Independent Study

December 9, 2009 vanderson 0

Derma Sciences, a developer of wound care products, announced that its Bioguard Barrier Dressings effectively safeguarded against the H1N1 “swine flu” virus in an independent laboratory study.

Biotech News Out of Quebec

October 11, 2009 vanderson 0

Medicago, a Canadian company focused on protein-based vaccines, has signed a contract with the U.S. Army to investigate ways to create biofuels from plants.

First Swine Flu Vaccines Approved

September 15, 2009 vanderson 0

The U.S. government has approved swine flu vaccines from four pharmaceutical companies, Reuters reports.

BioNeutral Ygiene Kills Swine Flu in 20 Seconds, Test Shows

August 22, 2009 vanderson 1

BioNeutral of Newark, NJ, announced that its Ygiene Consumer Grade antimicrobial formulation swiftly eradicated the H1N1 swine flu virus in an independent lab test.

Independent Study Validates BioNeutral’s Ygiene

July 8, 2009 vanderson 2

In an independent study, BioNeutral’s Ygiene antimicrobial formulation eliminated a particularly dangerous type of mold in record time.

OneMedPlace | Blog